[HTML][HTML] Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
EHTT Jayathilaka, DC Rajapaksha… - International Journal of …, 2021 - mdpi.com
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
EHTT Jayathilaka, DC Rajapaksha… - International …, 2021 - search.proquest.com
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
[HTML][HTML] Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
EHTT Jayathilaka, DC Rajapaksha… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
[PDF][PDF] Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
E Jayathilaka, DC Rajapaksha, C Nikapitiya… - Int. J. Mol. Sci, 2021 - academia.edu
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
EHTT Jayathilaka, DC Rajapaksha… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii.
E Jayathilaka, DC Rajapaksha, C Nikapitiya… - … Journal of Molecular …, 2021 - europepmc.org
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
EHTT Jayathilaka, DC Rajapaksha, C Nikapitiya… - 2021 - agris.fao.org
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
[PDF][PDF] Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
E Jayathilaka, DC Rajapaksha, C Nikapitiya… - Int. J. Mol …, 2021 - researchgate.net
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …
Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii.
EHT Jayathilaka, DC Rajapaksha… - International …, 2021 - search.ebscohost.com
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …
(MDR), the control of which has become challenging due to the currently used antibiotics …